Dipeptidyl peptidase-4 inhibitors: the different dosing requirements of adult patients with type 2 diabetes and comorbidities

Trajenta diabetes flyer v18 cover

This management algorithm has been commissioned and funded by Boehringer Ingelheim Limited.

Content for healthcare professionals

Access to this content is restricted to UK-based doctors, nurses, and pharmacists

If you are a UK-based doctor, nurse, or pharmacist, you must sign in to your account or register (for free) if you do not already have one. 

Return to homepage